Nasal hyperreactivity in rhinitis: A diagnostic and therapeutic challenge

被引:52
作者
Van Gerven, L. [1 ,2 ]
Steelant, B. [2 ]
Hellings, P. W. [1 ,2 ,3 ]
机构
[1] Univ Hosp Leuven, Clin Div Otorhinolaryngol Head & Neck Surg, Leuven, Belgium
[2] Katholieke Univ Leuven, Lab Clin Immunol, Dept Microbiol & Immunol, Leuven, Belgium
[3] Acad Med Ctr, Dept Otorhinolaryngol, Amsterdam, Netherlands
关键词
capsaicin treatment; cold-dry air provocation; diagnosis; nasal hyperreactivity; non-allergic rhinitis; POTENTIAL VANILLOID 1; COLD DRY AIR; PERENNIAL NONALLERGIC RHINITIS; EPITHELIAL BARRIER DYSFUNCTION; IRRITABLE-BOWEL-SYNDROME; HOUSE-DUST MITE; ALLERGIC RHINITIS; IDIOPATHIC RHINITIS; VASOMOTOR RHINITIS; DOUBLE-BLIND;
D O I
10.1111/all.13453
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Although nasal hyperreactivity (NHR) is a common feature in patients suffering from allergic and nonallergic rhinitis, it is widely neglected during history taking, underdiagnosed in the majority of patients with rhinitis and rhinosinusitis, not considered as an outcome parameter in clinical trials on novel treatments for rhinitis and rhinosinusitis, and no target for routine treatment. In contrast to the simple nature of diagnosing NHR by a history of nasal symptoms induced by nonspecific exogenous and/or endogenous triggers, quantification is hardly performed in routine clinic given the lack of a simple tool for its diagnosis. So far, limited efforts have been invested into gaining better insight in the underlying pathophysiology of NHR, helping us to explain why some patients with inflammation develop NHR and others not. Of note, environmental and microbial factors have been reported to influence NHR, contributing to the complex nature of understanding the development of NHR. As a consequence of the neglect of NHR as a key clinical feature of rhinitis and chronic rhinosinusitis (CRS), patients with NHR might be suboptimally controlled and/or dissatisfied with current treatment. We here aim to provide a comprehensive overview of current knowledge on the pathophysiology, and the available tools to diagnose and treat NHR.
引用
收藏
页码:1784 / 1791
页数:8
相关论文
共 59 条
[1]   Rhinovirus upregulates transient receptor potential channels in a human neuronal cell line: implications for respiratory virus-induced cough reflex sensitivity [J].
Abdullah, H. ;
Heaney, L. G. ;
Cosby, S. L. ;
McGarvey, L. P. A. .
THORAX, 2014, 69 (01) :46-U59
[2]   Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain [J].
Akbar, A. ;
Yiangou, Y. ;
Facer, P. ;
Walters, J. R. F. ;
Anand, P. ;
Ghosh, S. .
GUT, 2008, 57 (07) :923-929
[3]   SENSORY IRRITATION OF UPPER AIRWAYS BY AIRBORNE CHEMICALS [J].
ALARIE, Y .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1973, 24 (02) :279-297
[4]   Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin [J].
Apostolidis, A ;
Brady, CM ;
Yiangou, Y ;
Davis, J ;
Fowler, CJ ;
Anand, P .
UROLOGY, 2005, 65 (02) :400-405
[5]   Neuroregulation of Human Nasal Mucosa [J].
Baraniuk, James N. ;
Merck, Samantha J. .
INTERNATIONAL SYMPOSIUM ON OLFACTION AND TASTE, 2009, 1170 :604-609
[6]   CALCITONIN GENE-RELATED PEPTIDE IN HUMAN NASAL-MUCOSA [J].
BARANIUK, JN ;
LUNDGREN, JD ;
GOFF, J ;
MULLOL, J ;
CASTELLINO, S ;
MERIDA, M ;
SHELHAMER, JH ;
KALINER, MA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (02) :L81-L88
[7]   NEUROPEPTIDE-Y (NPY) IN HUMAN NASAL-MUCOSA [J].
BARANIUK, JN ;
CASTELLINO, S ;
LUNDGREN, JD ;
GOFF, J ;
MULLOL, J ;
MERIDA, M ;
SHELHAMER, JH ;
KALINER, MA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 3 (02) :165-173
[8]   SUBSTANCE-P AND NEUROKININ-A IN HUMAN NASAL-MUCOSA [J].
BARANIUK, JN ;
LUNDGREN, JD ;
OKAYAMA, M ;
GOFF, J ;
MULLOL, J ;
MERIDA, M ;
SHELHAMER, JH ;
KALINER, MA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1991, 4 (03) :228-236
[9]   Neurogenic inflammation in the airways [J].
Barnes, PJ .
RESPIRATION PHYSIOLOGY, 2001, 125 (1-2) :145-154
[10]   XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough [J].
Belvisi, Maria G. ;
Birrell, Mark A. ;
Wortley, Michael A. ;
Maher, Sarah A. ;
Satia, Imran ;
Badri, Huda ;
Holt, Kimberley ;
Round, Patrick ;
McGarvey, Lorcan ;
Ford, John ;
Smith, Jaclyn A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (10) :1255-1263